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We previously reported that aged mice demonstrated a 12-week delay in virus clearance compared to young mice after
infection with E55 murine leukemia retrovirus (E55MuLV). The current study demonstrates that both the levels of IL-2,
IFN-, and IL-10 and the number of cells producing IL-2 and IFN- were lower at 2 and 4 weeks postinfection (p.i.) in aged
compared to young mice after virus-specific stimulation of spleen cells in vitro. In both age groups, IL-2 and IL-10 were
produced by CD4 T and B cells, respectively. IFN- was produced mainly by CD4 T cells at 2 weeks p.i. and by CD4 and
CD8 T cells at 4 weeks p.i. in young, but primarily by CD8 T cells, in aged mice. Therefore, delayed virus clearance is
associated with age-related decreases in type 1 and type 2 cytokines and a shift in the primary source of at least onecell; CDINTRODUCTION
Aging is associated with an increased incidence of
virus infections (Schneider, 1983; Louria et al., 1993). This
increase has been attributed to age-related alterations in
both T cell mediated (Kirschmann and Murasko, 1992;
Goonewardene and Murasko, 1993; Chakravarti and
Abraham, 1999; Pawelec et al., 1999) and humoral
(LeMaoult et al., 1997; Song et al., 1997) immunity. The
age-releated decrease in immune function is also asso-
ciated with significant alterations in cytokine production.
Numerous studies have shown that a decrease in IL-2
production occurs with aging (Kirschmann and Murasko,
1992; Goonewardene and Murasko, 1993; Engwerda et
al., 1996; Wakikawa et al., 1999). Further, a limited num-
ber of studies has shown an age-related increase in
IL-10 production (Hobbs et al., 1994; Spencer et al., 1996).
While it has been postulated that aging is associated
with an increase in type 2 cytokines and a decrease in
type 1 cytokines, some studies have demonstrated an
age-associated increase in IFN- (Kirschmann and Mu-
rasko, 1992; Goonewardene and Murasko, 1993; Eng-
werda et al., 1996; Wakikawa et al., 1999) and others a
decrease in IFN- (Frasca et al., 1997; Fujo et al., 1995;
Taylor et al., 1997). In the majority of these cytokine
studies a polyclonal activator (e.g., concanavalin A (Con
A), anti-CD3 antibody) was used to stimulate cytokine
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8production. Only a limited number of studies has exam-
ined the effect of aging on antigen-specific cytokine
production (Frasca et al., 1997), and, importantly, the
effect of aging on cytokine production induced specifi-
cally by a virus during infection has not been directly
examined.
E55 murine leukemia virus (E55MuLV) is a repli-
cation-comptetent murine retrovirus that causes a
chronic infection, but fails to cause leukemia, in C57BL
strains of mice (Avidan et al., 1995). Infection of C57BL/6
(B6) mice is characterized by an acute and a persistent
phase. The acute phase is characterized by the pres-
ence of large numbers of virus-infected cells in the
spleen and bone marrow during the first 2–4 weeks
postinfection (p.i.). The number of virus-infected cells
decreases to undetectable levels by 8 weeks p.i. (Pan-
outsakopoulou et al., 1998). However, the virus is not
eradicated, with infected cells remaining sequestered in
lymphoid tissue during the persistent phase of infection
(Avidan et al., 1995; Panoutsakopoulou et al., 1998; Tu-
mas et al., 1993). The antivirus immune response has
been demonstrated to play an important role in control-
ling virus infection during the acute phase because
mice sublethally irradiated prior to inoculation with
E55MuLV demonstrate no clearance of virus (Avidan et
al., 1995; Panoutsakopoulou et al., 1998). We have previ-
ously reported that unlike 6-month-old (young) B6 mice
that decreased E55MuLV burden to undetectable lev-
els by 8 weeks p.i., the virus burden in 22-month-old
(aged) mice did not reach undetectable levels until 20cytokine. © 2002 Elsevier Science (USA)
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weeks p.i. (ElRefaei et al., 2001). This delay was not the
result of enhanced virus replication in aged mice: kinet-
ics of virus replication, peak titers, and tissue distribution
were comparable in young and aged mice (ElRefaei et
al., 2001). However, the delay in virus clearance was
associated with the lack of a T cell proliferative response
and significantly lower cytotoxic T cell response and
virus neutralizing antibody titers to E55MuLV in aged
compared to young B6 mice (ElRefaei et al., 2001).
In the present studies we utilized the E55MuLV
model to directly examine the effect of age on cytokine
production during virus infection. Cytokines were exam-
ined at 2 weeks p.i., the time of the initiation of a detect-
able T cell response, and at 4 weeks p.i., the time of peak
T cell response. All of the cytokines detected were sig-
nificantly reduced in age compared to young mice. The
lower levels of cytokines in aged mice were associated
with a decreased number of cells producing the cyto-
kines. With one cytokine the subset of T cells producing
the cytokine was also different in aged compared to
young mice. These results demonstrate that the ob-
served delay in E55MuLV clearance by aged mice is
associated with significant alterations in both type 1 and
type 2 cytokines.
RESULTS
T cell proliferation and IL-2 production by young and
aged mice
To directly examine age-associated alterations in T
cell proliferation and cytokine production during
E55MuLV infection, groups of young and aged B6 mice
were infected with E55MuLV and then sacrificed either
at 2 or 4 weeks p.i.
Spleen cells from young mice generated a significant
proliferative response to E55MuLV at 2 and 4 weeks
p.i. (Fig. 1). In contrast, spleen cells from aged mice
failed to generate a significant proliferative response at
either time. CD4 T cells mediated the proliferative re-
sponse of young mice because in vitro depletion of these
cells prior to stimulation completely abolished prolifera-
tion. In contrast, in vitro depletion of the CD8 T cells had
no effect on the response of either age group (data not
shown).
To determine if the lack of proliferation by spleen cells
of aged mice was associated with decreased IL-2 pro-
duction, supernatants from in vitro cultures were tested
by ELISA for the presence of IL-2. Culture supernatants
of spleen cells from young mice cultured either alone or
with uninfected IC21 cells contained significantly higher
levels of IL-2 than culture supernatants of spleen cells
from aged mice at 2 weeks p.i. (P  0.006; Table 1).
Although IL-2 levels increased significantly from 2 to 4
weeks in the culture supernatants of spleen cells from
aged, but not young, mice (P  0.04), IL-2 levels were
still higher in culture supernatants of spleen cells from
young mice at 4 weeks (P  0.04). Contrary to our
expectations, culture with E55MuLV-infected IC21 cells
resulted in a significant decrease in IL-2 levels relative to
IL-2 levels of cultures with uninfected IC21 cells (P 
0.02) by spleen cells from young and aged mice at both
times. However, IL-2 levels were still significantly higher
in culture supernatants of spleen cells from young mice
(P  0.04).
To determine if the decrease in IL-2 levels in cultures
of spleen cells from aged mice was associated with a
decreased number of IL-2 producing cells, spleen cells
cultured with E55MuLV-infected IC21 cells were used
in an indirect ELISPOT assay. Similar to the results of the
ELISA, aged mice had significantly lower numbers of
cells producing IL-2 than young mice at both 2 and 4
weeks p.i. In contrast to the results of the ELISA, virus-
specific stimulation in vitro did not result in a significant
decrease in the number of IL-2 producing cells in either
age group compared to culture alone (data not shown) or
with uninfected IC21 cells (Fig. 2A). In addition, there was
no increase in the number of IL-2-producing cells at 4
compared to 2 weeks. CD4 T cells were the main
source of IL-2 in both age groups because depletion of
the CD4, but not CD8 (data not shown), cells prior to
culture significantly decreased the level of IL-2 in the
supernatant detected by ELISA (Table 1) and the number
of IL-2-producing cells detected by inidrect ELISPOT
(data not shown).
The contrasting data from the ELISA and the indirect
ELISPOT suggested that in vitro culture has a major
FIG. 1. T cell proliferative response to E55MuLV of young and aged
mice. Spleen cells from individual E55MuLV-infected B6 mice at 2
and 4 weeks p.i. were cultured with either uninfected or E55MuLV-
infected IC21 cells. Aliquots of the spleen cells were depleted in vitro
of either CD4 or CD8 T cells prior to culture. Proliferation is ex-
pressed as net counts per minute (Net CPM). Values are means SEM
of a total of 9–12 mice/group evaluated in three separate experiments.
Values of both the control group (spleen cells cultured with uninfected
IC21 cells) and the CD4 cell-depleted group are means SEM of both
times p.i. Statistically significant differences as determined by Stu-
dent’s t test: (*) Uninfected IC21 cells vs infected IC21 cells of the same
age group, P  0.014; (#) Young vs aged at the same time p.i., P 
0.025; () No depletion vs () CD4 cells of the same age group, P 
0.014. Differences between 2 and 4 weeks p.i. were not statistically
significant.
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influence on the results obtained. To more closely reflect
the in vivo situation, spleen cells from E55MuLV-in-
fected mice were used in direct ELISPOT assays.
E55MuLV infection resulted in detectable numbers of
IL-2-producing cells in both age groups at 2 weeks (P 
0.04) that increased significantly by 4 weeks p.i. (Fig. 2B,
P  0.03). Consistent with both the ELISA and the
indirect ELISPOT, the number of IL-2-producing cells was
significantly higher in young compared to aged mice
(P  0.05) at both times. However, the number of IL-2-
producing cells detected by direct ELISPOT was signifi-
cantly lower than the numbers obtained by indirect
ELISPOT in both age groups at both times (P  0.02).
These data suggest that in vitro culture of spleen cells
either alone or with IC21 cells results in a significant
increase in the number of IL-2-producing cells in both
age groups. Importantly, data from all the assays indi-
cated that CD4 T cells are responsible for IL-2 produc-
tion in both age groups: depletion of CD4, but not CD8,
cells prior direct ELISPOT assay decreased the number
of IL-2-producing cells to levels comparable to those
seen in cultures of naı¨ve spleen cells (data not shown).
IFN- production by young and aged mice
Since the effect of aging on IFN- production during
virus infection has not been clearly demonstrated, we
evaluated IFN- production during the acute phase of
E55MuLV infection. The amount of IFN- in the super-
natants of in vitro cultures that were assessed for prolif-
eration was determined by ELISA. At 2 weeks p.i., eight
of the nine young mice, while only two of the nine aged
mice produced detectable IFN- levels (Fig. 3). At 4
weeks p.i., all the young mice tested (nine mice) had
detectable IFN-, while only 8 of the 10 aged mice had
detectable IFN-. Although the mean IFN- levels were
not significantly higher at 4 compared to 2 weeks p.i. in
FIG. 2. Number of IL-2 producing cells following E55MuLV-specific
stimulation of spleen cells in vitro. Spleen cells from individual B6 mice
were cultured either alone or with IC21 cells and then used in either
indirect (A) or direct (B) ELISPOT assays. Data shown are means 
SEM of nine individual mice/group evaluated in three separate exper-
iments. Values of the control group (spleen cells cultured with unin-
fected IC21 cells) are means  SEM of both times p.i. For the indirect
ELISPOT, spleen cells from infected mice of both age groups cultured
either alone or with uninfected IC21 cells produced comparable num-
bers of IL-2-producing cells/106 cells. Naı¨ve spleen cells cultured either
alone or with IC21 cells produced 10 IL-2 producing cells/106 cells.
Statistically significant differences as determined by Mann–Whitney U
test: (*) Young vs aged at the same time p.i. and under similar condi-
tions, P  0.02; (#) Naı¨ve vs infected of the same age group, P  0.04;
() 2 weeks vs 4 weeks p.i. of the same age group, P  0.03.
Differences between uninfected and infected IC21 cells of the same
age group, and between 2 and 4 weeks p.i. of the same age group were
not statistically significant for indirect ELISPOT (A).
TABLE 1
IL-2 Production by Young and Aged C57BL/6 Micea
Age Weeks p.i.
Infected splenocytes cultured with
Uninfected IC21 Infected IC21
Intact Intact () CD4
6 months 2 101 21b 54 11b,c 18 2d
4 136 24b 76 9b,c 22 4d
22 months 2 26 5 16 2c 15
4 78 17e 46 10c,e 19 2d
a Spleen cells from individual B6 mice were stimulated in vitro with
IC21 cells. Culture supernatants were assayed by ELISA and results
were expressed in pg/ml. Values are means  SEM of nine individual
mice/group evaluated in three separate experiments. Culture superna-
tants from infected spleen cells cultured either alone or with uninfected
IC21 cells contained comparable levels of IL-2 (data not shown). Cul-
ture supernatants from infected spleen cells cultured with uninfected
IC21 cells but depleted of CD4 T cells prior to culture contained 20
pg/ml of IL-2. Culture supernatant from naı¨ve spleen cells contained
below detectable levels of IL-2. Statistically significant differences as
determined by Mann–Whitney U test:
b Young vs aged, P  0.006 and P  0.04 at 2 and 4 weeks p.i.,
respectively.
c IL-2 levels of uninfected IC21 cells vs infected IC21 cells of the
same age group, P  0.02.
d Intact vs () CD4 depletion of the same age group, P  0.005.
e 2 weeks vs 4 weeks p.i. in aged mice, P  0.04.
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either age group, young mice had significantly higher
mean IFN- levels than aged mice at both 2 (P  0.03)
and 4 (P  0.04) weeks p.i. These results suggested
that aged mice demonstrate a delay in the production of
IFN-, as well as significantly lower mean IFN- levels
compared to young B6 mice.
To determine whether the decreased IFN- production
in aged mice was associated with a decreased number
of IFN- producing cells, spleen cells cultured with
E55MuLV-infected IC21 cells were used in an indirect
ELISPOT assay. At 2 weeks p.i., virus-specific stimulation
resulted in a detectable number of IFN--producng cells
in only young mice (Fig. 4A). At 4 weeks p.i., IFN--
producing cells were detectable in both age groups;
however, the number of IFN- producing cells was sig-
nificantly higher at 4 compared to 2 weeks p.i. in young
(P  0.01), but not aged, mice (Fig. 4B). At both times,
the number of virus-specific IFN- producing cells was
significantly higher in young compared to aged B6 mice
(P  0.02). These results indicate that the lower IFN-
level observed in supernatants was associated with sig-
nificantly fewer IFN--producing cells in the spleen of
aged B6 mice. We were unable, however, to detect any
IFN--producing cells by direct ELISPOT.
To determine the contribution of T cell subsets to
E55MuLV-specific IFN- production in young and aged
B6 mice, spleen cells were depleted of CD4 or CD8 T
cells prior to culture. At 2 weeks p.i., depletion of the
CD4 T cells of young mice decreased the number of
E55MuLV-specific IFN--producing cells to levels com-
parable to those seen in culture of unstimulated spleen
cells (P  0.04; Fig. 4A). Depletion of the CD8 T cells,
however, decreased the number of E55MuLV-specific
IFN- producing cells in only two of six mice, resulting in
a mean 45% reduction compared to the undepleted con-
trols. At 4 weeks p.i., depletion of either T cell subset in
young mice resulted in a significant decrease in the
number of IFN- producing cells (P  0.04; Fig. 4B), with
a reduction of 63 and 77% upon depletion of CD4 and
CD8 T cells, respectively. These results suggest that
about 25% of IFN- is directly produced by CD4 T cells.
While 75% of the IFN- in young mice appear to be
produced by CD8 T cells, about half of this seems to be
dependent on the presence of both CD4 and CD8 T
cells: Depletion of CD4 T cells results in a 60% reduc-
FIG. 4. Number of IFN- producing cells following E55MuLV-spe-
cific stimulation of spleen cells in vitro. Spleen cells from individual B6
mice at 2 (A) and 4 (B) weeks p.i. were cultured with either uninfected
or E55MuLV-infected IC21 cells. Cells were then used in indirect
ELISPOT assays and results were expressed as net IFN- producing
cells/106 cells. Data shown are means  SEM of nine individual
mice/group evaluated in three separate experiments. Aliquots of the
spleen cells were depleted of CD4 or CD8 T cells prior to culture.
Naı¨ve spleen cells cultured either alone or with IC21 cells produced
10 IFN--producing cells/106 cells. Statistically significant differences
as determined by Mann–Whitney U test: (*) Young vs aged at the same
time p.i., P  0.02; () No depletion vs () CD4 or () CD8 cells of
the same age group and time p.i., P  0.04; (#) 2 weeks vs 4 weeks
p.i. of the same age group and under similar conditions, P  0.01.
FIG. 3. IFN- production following E55MuLV-specific stimulation of
spleen cells in vitro. Spleen cells from B6 mice were cultured with
either uninfected or E55MuLV-infected IC21 cells. Culture superna-
tants were assayed by ELISA and results were expressed as net IFN-
levels in pg/ml (Net pg/ml). Data are from 9–10 individual mice/group
evaluated in three separate experiments. Bars represent the mean
IFN- level/group. Culture supernatants of spleen cells from naı¨ve B6
mice contained below detectable levels of IFN-. Statistically signifi-
cant differences as determined by Mann–Whitney U test: (**) Young vs
aged, P  0.03 and P  0.04 at 2 and 4 weeks p.i., respectively.
Differences between 2 and 4 weeks p.i. were not statistically significant
in either age group.
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tion of IFN--producing cells. However, since 25% of
IFN--producing cells are CD4 T cells, the remaining
35% reduction must be due to interactions of CD8 T
cells with CD4 T cells.
In contrast, depletion of the CD8 T cells of aged mice
resulted in a significant decrease (82%) in the number of
IFN--producing cells (P  0.04), while depletion of
CD4 T cells had no significant effect, only reducing the
number of IFN--producing cells by 22%. These results
suggest not only that about 85% of the cells producing
IFN- are CD8 T cells, but also that most of these CD8
T cells are capable of this production without help from
CD4 T cells, as indicated by the congruence of CD8
and CD4 T cell depletion data (i.e., 18% of residual
production by CD4 T cells in the former and a 22%
reduction in the latter). In support of this conclusion, in 3
of 10 aged mice, CD4 T cell depletion had no effect on
the number of cells producing IFN-. Similar results were
observed by depletion of CD4 or CD8 T cells prior to
culture of cells for the ELISA assay (data not shown).
These results indicate that aged mice demonstrate an
alteration in the phenotype of the cells that produce
IFN- following E55MuLV-specific stimulation of
spleen cells in vitro.
IL-10 production by young and aged mice
Since aging is thought to be associated with an in-
crease in type 2 cytokines such as IL-10 (Hobbs et al.,
1994; Spencer et al., 1996), we assessed IL-10 production
during the acute phase of E55MuLV infection. At 2
weeks p.i., young mice demonstrated significantly higher
levels of IL-10 (P  0.04) in the supernatant of spleen
cell cultures stimulated with E55MuLV compared to
unstimulated spleen cells (data not shown). Contrary to
expectations, aged mice showed no significant increase
in IL-10 levels upon virus-specific stimulation of spleen
cells in vitro (Fig. 5A). Virus-specific stimulation resulted
in significantly higher mean IL-10 levels at 4 compared to
2 weeks p.i. in both age groups (P  0.015). However,
supernatants of spleen cell cultures from young mice
had significantly higher mean IL-10 levels than aged
mice (P  0.05; Fig. 5B). We tried to determine whether
the decreased IL-10 production in aged mice was asso-
ciated with a decreased number of IL-10-producing cells.
However, we were unable to detect any IL-10 producing
cells by direct or indirect ELISPOT assays in either age
group possibly because the amount of IL-10 produced by
the spleen cells was below the limit of detection of the
assay.
To determine the source(s) of the IL-10, spleen cells
were depleted of either CD4 or CD8 T cells or CD19
B cells prior to culture. At 2 weeks p.i., in vitro depletion
of either T cell subset resulted in a 50% decrease in IL-10
levels in young B6 mice (P  0.05). However, in vitro
depletion of CD19 B cells resulted in reduction in IL-10
levels to background levels (P  0.02; Fig. 5A). At 4
weeks p.i., in vitro depletion of CD19 cells resulted in a
decrease in IL-10 to background levels (P  0.02; Fig.
5B). Interestingly, depletion of CD4, but not CD8, T
cells resulted in a 50% decrease in IL-10 production by
spleen cells of young mice (P  0.05), while depletion
of either T cell subset had no effect on IL-10 production
by spleen cells of aged mice.
Since IL-4 is another type 2 cytokine, we tried to
determine the level of IL-4 in the culture supernatant, as
well as the number of IL-4-producing cells, following
E55MuLV-specific stimulation of spleen cells from B6
mice. However, IL-4 levels were below detection in both
age groups. These results may reflect the sensitivity of
FIG. 5. IL-10 production following E55MuLV-specific stimulation of
spleen cells in vitro. Spleen cells from individual B6 mice at 2 (A) and
4 (B) weeks p.i. were cultured with either uninfected or E55MuLV-
infected IC21 cells. Culture supernatants were assayed by ELISA and
results were expressed as net IL-10 levels in pg/ml. Data are means 
SEM of 9–12 individual mice evaluated in three separate experimetns.
Aliquots of the spleen cells were depleted of CD4 or CD8 T cells or
CD19 B cells prior to culture. Culture supernatants of spleen cells
from naı¨ve B6 mice contained below detectable levels of IL-10. Statis-
tically significant differences as determined by Mann–Whitney U test:
(*) Young vs aged at the same time p.i., P  0.05; () No depletion vs
() CD4 or () CD8 cells of the same age group and time p.i., P 
0.05. () No deletion vs () CD19 cells of the same age group and
time p.i., P  0.02. (#) 2 weeks vs 4 weeks p.i. of the same age groups
and under similar conditions, P  0.015.
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these assays and/or the amount of IL-4 produced follow-
ing E55MuLV infection, since we were able to detect
both IL-4 in culture supernatant and IL-4-producing cells
when aliquots of the spleen cell preparations were stim-
ulated with Con A (data not shown). These results, how-
ever, were consistent with previous studies that showed
IL-4 production by spleen cells of young E55MuLV-
infected B6 mice upon anti-CD3 mAb stimulation in vitro
were below detectable level (Panoutsakopoulou et al.,
1998).
DISCUSSION
Numerous studies have demonstrated that the age-
related decrease in immune function is associated with
significant alterations in cytokine production (Kir-
schmann and Murasko, 1992; Goonewardene and Mu-
rasko, 1993; Wakikawa et al., 1999; Taylor et al., 1997;
Hobbs et al., 1991; Ernst et al., 1993). However, the effect
of increasing age on antigen-specific cytokine produc-
tion during a virus infection has not been examined.
Previously, we utilized the E55MuLV model to investi-
gate the relationship between decreased immune re-
sponsiveness and diminished control of primary virus
infections in aged mice (ElRefaei et al., 2001). Results
showed that E55MuLV infection of aged B6 mice is
characterized by a considerable delay in virus clearance
compared to young B6 mice. The delay in virus clearance
by aged mice was associated with the lack of a T cell
proliferative response to E55MuLV and significantly
lower cytotoxic T cell responses and virus-neutralizing
antibody titers to E55MuLV. In the current studies we
utilized the E55MuLV model to examine the effect of
increasing age on antigen-specific cytokine production.
Three main questions were addressed within the con-
text of virus-specific antigenic stimulation. Assuming that
we would observe an alteration in cytokine production,
we asked: First, is the age-associated alteration in cyto-
kine production consistent with a shift from a type 1 to a
type 2 response? Second, does this alteration represent
a change in the kinetics of cytokine production with age?
Third, is this alteration due to a change in the number of
cells producing the cytokine, a change in the amount of
cytokine being produced per cell, and/or a change in the
type of cell that is producing the cytokine?
Many studies that have examined age-associated
changes in cytokine production have evaluated the level
of cytokine in supernatants after stimulation of lympho-
cytes. Therefore, our first assessment was quantitation
of cytokine in the supernatants of spleen cultures at
times corresponding to maximum proliferation in vitro.
For all three cytokines that were detectable, i.e., IL-2,
IL-10, and IFN-, the level of cytokine detected in the
supernatants of spleen cells from aged mice was signif-
icantly lower than that observed in young mice. This
finding was consistent with previous studies showing
decreased IL-2 production upon lymphocyte stimulation
(Kirschmann and Murasko, 1992; Goonewardene and
Murasko, 1993; Engwerda et al., 1996; Wakikawa et al.,
1999). It has also been postulated that increased age
results in a shift from a type 1 to a type 2 cytokine
response (Shearer, 1997). Consistent with this hypothe-
sis, a decrease in IFN- production in response to
E55MuLV infection was also observed in aged mice.
An age-associated shift from a type 1 to a type 2
response would also predict that there would be an
increase in IL-10 production with increasing age. The
limited number of studies that examined IL-10 production
have indeed observed an increase in IL-10 production by
T cells from aged compared to young mice (Hobbs et al.,
1994; Spencer et al., 1996). However, in contrast to our
expectations, a decrease in IL-10 in the cultures from
aged compared to young mice were observed. These
results of the E55MuLV system are consistent with
studies of influenza stimulation of peripheral blood lym-
phocytes of elderly humans after influenza vaccination
(Bernstein et al., 1998): the level of all detectable cyto-
kines is decreased in elderly compared to young after
virus-specific stimulation.
The next question was whether or not this decrease in
cytokine production merely represented a shift in the
kinetics of cytokine production. The current study chose
two time points for assessment of cytokine production: 2
weeks and 4 weeks p.i. Two weeks reflect the first time
postinfection that there is a detectable response to
E55MuLV infection by either proliferation or cytotoxic T
cell activity in young mice (Panoutsakopoulou et al.,
1998; ElRefaei et al., 2001). The level of proliferative
response in young mice increases to a maximum level at
4 weeks p.i. and this level is maintained through at least
12 weeks p.i. In aged mice, there is no significant prolif-
eration at any time through 12 weeks p.i.; however, there
is detectable cytotoxic T cell activity, which peaks at 4
weeks p.i. (ElRefaei et al., 2001). Therefore, 2 weeks
represent the initiation of a detectable immune re-
sponse, in at least young animals, with 4 weeks being
the time of maximal T cell activity of both young and aged
mice. An increase in the level of all three cytokines was
observed from 2 to 4 weeks p.i. in both young and aged
mice. For all three cytokines, the magnitude of the in-
crease from week 2 to week 4 was greater in aged than
in young mice. For IL-2 and IFN-, the level of cytokine
detectable in supernatants of cultures of spleen cells
from young mice increased approximately 30% from 2 to
4 weeks p.i., while in aged mice it increased two- to
threefold. IL-10 increased approximately twofold in cul-
tures of spleen cells from young mice, but increased
approximately fourfold from 2 to 4 weeks in cultures of
spleen cells in aged mice. Regardless of the fold in-
crease, the level of cytokines observed in cultures of
spleen cells of young mice was consistently and signif-
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icantly higher than the level observed in cultures of aged
animals.
The fact that there was no significant proliferation
detectable in the spleen cell cultures of aged mice at
either 2 or 4 weeks p.i. in the presence of IL-2 production
suggests that aged mice are able to synthesize, but not
utilize, IL-2. Since this decreased utilization of IL-2 would
result in decreased proliferation, we predicted that the
number of cells producing IL-2 would be decreased in
aged mice and that this may occur either independently
or in conjunction with a decrease in the level of IL-2
produced per cell. To explore whether or not the de-
crease in the level of IL-2 was associated with a de-
creased number of cells producing IL-2, we utilized the
ELISPOT assay. To maximize the sensitivity of the assay,
we followed the protocol of previous studies (Taguchi et
al., 1990) and cultured spleen cells with antigen for 2
days prior to assessing cytokine secretion in the
ELISPOT assay (indirect ELISPOT). Similar to the results
obtained with the ELISA assay, there were fewer cells
producing IL-2 in spleen cells from aged mice compared
to spleen cells from young mice at both 2 and 4 weeks
p.i. Intriguingly, however, there was no increase in the
number of cells producing IL-2 from 2 to 4 weeks p.i. in
either young or aged mice. Since the amount of IL-2 in
the supernatant increased from 2 to 4 weeks p.i., the lack
of an increase in the number of cells could suggest that
the same number of cells are simply producing more IL-2
at 4 compared to 2 weeks p.i..
One concern with the indirect ELISPOT is that it in-
cludes a 48-h culture with antigen prior to quantitation of
the cells producing the cytokine. Data from the ELISA
suggested that lymphocytes were expanding during the
48-h culture since supernatants from spleen cells cul-
tured alone or with uninfected IC21 cells contained more
IL-2 than supernatants from spleen cells cultured with
infected IC21 cells. If lymphocytes of aged mice fail to
proliferate in response to IL-2 in vitro, it is possible that
the difference in the number of IL-2-producing cells be-
tween aged and young mice as detected by indirect
ELISPOT is larger than the difference that occurs in vivo.
To address this possibility, we used a direct ELISPOT in
which spleen cells were directly plated on the cytokine
detection plate.
Results from the direct ELISPOT suggested that the
extended culture prior to the indirect ELISPOT was influ-
encing the results: the number of IL-2-producing cells
detected in the direct ELISPOT was smaller at both times
and in both age groups. Further, the in vitro culture
appeared to maximally expand all virus-reactive lympho-
cytes, since the indirect ELISPOT had no increase from 2
to 4 weeks p.i., while the direct ELISPOT demonstrated a
significant increase from 2 to 4 weeks p.i. However, the
extended culture did not appear to amplify the difference
between young and aged mice: there is a 40–50% de-
crease in the number of IL-2-producing cells in the aged
mice in both assays and at both times.
Interpretation of data from all three assessments of
IL-2 is consistent with the hypothesis that the decrease
in IL-2 levels in culture supernatant of spleen cells from
young mice following E55MuLV-specific stimulation is
due to consumption of IL-2 by T cells proliferating during
the extended culture. This explanation does not appear
to account for the decrease in IL-2 levels following virus-
specific stimulation in aged mice; there is no significant
antigen-specific proliferation in aged mice at either time
as detected by 3H-thymidine incorporation. However,
while the overall level of proliferation of spleen cells of
aged mice is not significant, there is an expansion in
culture of the cells producing IL-2 in aged mice as
illustrated by the higher number of IL-2 producing cells in
the indirect vs direct ELISPOT. These IL-2-producing
cells may be the primary cell utilizing the IL-2 that is
produced. Althugh the above is the most likely explana-
tion for the decrease in IL-2 upon in vitro culture with
E55MuLV-infected IC21 cells, E55MuLV may have
inhibited IL-2 production by splenic-CD4 T cells from
both age groups. In the closely related FV system, spleen
cells from infected mice at 14–28 days p.i. suppressed
production of IL-2 by normal spleen cells upon stimula-
tion with Con A in vitro (Matteucci et al., 1989).
The effect of aging on IFN- production is unclear.
Some reports showed that T cells from aged B6 mice
produced significantly more IFN- than T cells from
young mice when stimulated with either anti-CD3 mAb,
Con A, or phorbol myristate acetate (PMA)/ionomycin
(Kirschmann and Murasko, 1992; Engwerda et al., 1996;
Wakikawa et al., 1999; Nagelkerken et al., 1991). In addi-
tion, flow cytometric analysis of spleen cells from aged
mice following anti-CD3 mAb stimulation showed a sig-
nificant increase in the percentage of IFN--positive
cells compared to spleen cells from young mice
(Wakikawa et al., 1999). In contrast, other studies showed
significantly lower IFN- production by Con A or super-
antigen-stimulated spleen cells from aged compared to
young B6 mice (Frasca et al., 1997; Fujio et al., 1995).
In the current studies, a delay in the production, as
well as significantly lower levels, of IFN- were observed
in aged compared to young mice upon E55MuLV-spe-
cific stimulation of spleen cells at 2 and 4 weeks p.i.
Decreased IFN- production was associated with de-
creased numbers of IFN--producing cells in the spleen
of aged mice. There was an increase in the number of
cells producing IFN- in both young and aged mice at 4
compared to 2 weeks p.i. However, the percentage in-
crease observed in the indirect ELISPOT assay did not
directly relate to the increase observed in the ELISA: the
level of IFN- in the supernatant of spleen cells from
young mice increased about 30% from 2 to 4 weeks p.i.,
while the number of cells producing cytokines tripled. In
aged mice the level of IFN- in culture supernatant in-
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creased approximately twofold, while the number of cells
producing IFN- increased approximately fivefold. The
results suggested that either less IFN- is being made
per cell as the immune response proceeds or that as
IFN- is being made, it is utilized by the expanded num-
ber of cells.
Interestingly, the age-associated decrease in IFN-
production was associated with a shift in the primary
source of IFN- in aged mice. In young mice, splenic
CD4 T cells were not only required for IFN- production
at 2 weeks p.i., but appeared to be responsible for most
of the IFN- production. By 4 weeks p.i., while both CD4
and CD8 T cells contributed to IFN- production, most
of the IFN- was produced by CD8 T cells and about
35% of the production by CD8 T cells was independent
of CD4 T cells. In contrast, depletion of CD4 T cells
had little effect on IFN- production in aged mice, indi-
cating that the CD8 T cells of aged mice were not only
the main source of IFN- but also they did not require
CD4 T cell help for IFN- production.
The age-associated alteration in IFN- production has
not been clearly attributed to a specific subpopulation of
T cells. Studies showed that both splenic CD4 (Eng-
werda et al., 1996; Wakikawa et al., 1999; Hobbs et al.,
1993) and CD8 (Engwerda et al., 1996; Wakikawa et al.,
1999; Ernst et al., 1993) T cells from aged B6 mice
produced higher levels of IFN- than the corresponding
cells from young mice upon anti-CD3 mAb or anti-CD3
mAb/antiCD28 mAb stimulation in vitro. While an age-
associated increase in IFN- was observed in both
CD4 and CD8 T cells, the difference in IFN- produc-
tion between young and aged was much greater in CD8
T cells (Engwerda et al., 1996). Flow cytometric analysis
of spleen cells from aged mice also showed that the
percentage of IFN--positive/CD8 cells was signifi-
cantly higher than the percentage of IFN--positive/
CD4 cells (Wakikawa et al., 1999). These results are
consistent with our observation that CD8 T cells are the
main source of IFN- in aged mice.
IFN- is required for clearance of some virus infec-
tions. For example, B6 mice treated in vivo with anti-
IFN- mAb during acute cutaneous herpes simplex virus
infection failed to clear virus by 8 days p.i., whereas all
control mice treated with normal rat IgG cleared virus
efficiently (Smith et al., 1994). Similarly, FV infection re-
sulted in a significant increase in the production of IFN-,
as well as an increase in the number of IFN--producing
CD4 and CD8 T cells at 7–12 days p.i. (Peterson et al.,
2000). In addition, in vivo treatment with anti-IFN- mAb
during FV infection suppressed recovery from FV-in-
duced splenomegaly until at least day 37 p.i., while all
mice treated with normal anti-rat immunoglobulin (Ig)
recovered from FV-induced splenomegaly by 18 days p.i.
(Peterson et al., 2000). While young IFN- knock-out B6
mice can clear E55MuLV by 8 weeks p.i., young BALB
mice do require IFN- for E55MuLV clearance (Panout-
sakopoulou et al., 1998). Therefore, it is possible that
aged B6 mice may be more similar to BALB mice and
that the delayed and decreased levels of IFN- may be a
major factor in the delayed E55MuLV clearance in
aged mice.
IL-10 plays a key regulatory role in inhibiting produc-
tion of type 1 cytokines, thus downregulating cell-medi-
ated responses. IL-10 inhibited Con A-induced IL-2 pro-
duction by T cells (Ding and Shevach, 1992), and it also
suppressed the ability of macrophages to stimulate Th-1
cell clones to synthesize IFN- (Fiorentino et al., 1991). A
limited number of studies showed that aging is associ-
ated with increased IL-10 production. Splenic CD4 cells
from aged B6 mice that were stimulated with anti-CD3
mAb in vitro produced significantly higher levels of IL-10-
and IL-10-specific mRNA compared to the corresponding
cells from young B6 mice (Hobbs et al., 1994). In other
studies, spleen and peritoneal exudate cells from aged
CBA mice cultured for 24 h without or with stimulation by
endotoxin produced significantly higher IL-10 levels com-
pared to cells isolated from younger mice (Spencer et al.,
1996). We, therefore, hypothesized that an age-related
increase in IL-10 production would be associated with
the decreased cell-mediated immune response to
E55MuLV resulting in delayed virus clearance in aged
mice. Contrary to our expectations, spleen cells from
aged mice 2 and 4 weeks p.i. produced significantly
lower levels of IL-10 compared to spleen cells from
young mice upon E55MuLV-specific stimulation in
vitro. These results demonstrate that the lack of
E55MuLV-specific T cell proliferation by spleen cells of
aged B6 mice is not associated with an increase in IL-10
production.
IL-10 is produced by both T and B cells. In vitro lym-
phocyte subset depletions of spleen cells from B6 mice
infected with murine gammaherpes virus 68 (MHV-68)
demonstrated that both T and B cells produced IL-10
upon restimulation with virus-infected spleen cells
(Sarawar et al., 1996). Although our results showed that
B cells were required for IL-10 production during the
acute phase of E55MuLV infection in both age groups,
in young mice either CD4 or CD8 T cells were also
needed for IL-10 production. In contrast, depletion of
either CD4 or CD8 T cells had little effect on IL-10
levels in the culture supernatant of spleen cells from
aged mice, indicating that T cells did not contribute to
IL-10 production in aged B6 mice. These results provide
further evidence that an alteration in CD4 T cell function
occurs in aged B6 mice and that aged mice may develop
alternative mechanisms for cytokine production.
Finally, our results also showed that E55MuLV infec-
tion was associated with increased IL-10 production by
spleen cells from mice of both age groups compared to
spleen cells from uninfected mice. These results are
consistent with other studies that demonstrated in-
creased IL-10 production during virus infection. Intrana-
15DECREASED CYTOKINE PRODUCTION BY AGED MICE
sal infection of B6 mice MHV-68 resulted in increased
IL-10 production by spleen and lymph node cells after in
vitro restimulation with virus-infected spleen cells
(Sarawar et al., 1996). Spleen cells from B6 mice, 1 week
postinfection with a mixture of murine leukemia viruses
(LP-BM5), produced higher levels of IL-10 when cultured
without antigenic stimulation and when stimulated with
Con A compared to spleen cells from uninfected mice
(Gazzinelli et al., 1992). In other studies the expression of
IL-10 mRNA was upregulated in both the thymus and the
lymph nodes of feline immunodeficiency virus infected
cats (Liang et al., 2000). The production of high levels of
IL-10 during virus infection may play a role in the estab-
lishment and maintenance of persistent E55MuLV in-
fection.
In summary, E55MuLV provides a unique model in
which age-associated changes in the immune response
to a virus infection can be explored. Since the virus
infection persists for more than 2 months, an extensive
evaluation of the entire range of immune responses can
occur. We have previously established that aged mice
demonstrate both a decrease and a delay in both anti-
body and cytotoxic T cell responses. The current data
clearly show a decreased proliferative and cytokine re-
sponse as well. Importantly, the decrease in cytokine
production occurs in both type 1 (IL-2 and IFN-) and
type 2 (IL-10) cytokines, challenging one hypothesis of
immunosenscence that suggests that there is a shift
from type 1 to type 2 cytokine response with age. The
reduction in cytokine levels was associated with a lower
number of cytokine-producing cells. In addition, there
was a shift in the primary source of IFN- from CD4 to
CD8 T cells in aged mice. Further, the dependence of
IFN- and IL-10 production on T cell help appears to
abate with increased age. The lack of significant virus-
induced proliferation, decreased IL-2 production, and
increased contribution of CD8 T cells to IFN- produc-
tion support other studies that emphasize the negative
impact of aging on CD4 T cell function. However, since
CD4 T cells are required for reduction of E55MuLV
titers in young B6 mice and since aged B6 mice can still
reduce E55MuLV titers, this system illustrates that the
aging immune system may develop compensatory mech-
anisms to control virus infections.
MATERIALS AND METHODS
Mice
Six-month- and 22-month-old C57Bl/6 (B6) male mice
were purchased from the NIA colony of Charles River
Laboratories. All mice were housed in AAALAC-certified
barrier facilities at MCP Hahnemann University and were
given autoclaved food and water ad libitum. Mice were
allowed to acclimate for at least 2 weeks in our facilities
prior to use. Mice demonstrating tumors of any kind were
eliminated from the study.
Virus
E55 murine leukemia virus (E55MuLV) was origi-
nally isolated from a BALB.K spleen injected with cell-
free culture supernatant from a T cell line derived from a
leukemic mouse (Pozsgay et al., 1989). The virus used in
these studies was propagated in vivo by i.p. injections of
immunosuppressed BALB/c mice (Wolf and Blank, 1983).
All mice used in the studies were injected i.p. with 4 
104 focus forming units (FFU) of E55MuLV.
Antibodies
Hybridoma cells producing the monoclonal antibodies
(mAb) mAb34, specific for the p15-gag protein, and
mAb48, specific for the gp70 envelope protein (Chese-
boro et al., 1981), were a gift from Dr. Bruce Chesebro.
Hybridoma cells producing the mAb GK1.5 (anti-CD4)
and mAb 2.43 (anti-CD8) were obtained from American
Type Culture Collection (ATCC, Rockville, MD). Antibod-
ies were purified using protein A-sepharose affinity chro-
matography (Ey et al., 1978). Rat anti-mouse IL-2 mAb
(clone JES6-1A12), biotinylated rat anti-mouse IL-2 mAb
(clone JES6-5H4), rat anti-mouse IL-10 mAb (clone JES5-
2A5), biotinylated rat anti-mouse IL-10 mAb (clone SXC-
1), rat anti-mouse IFN- mAb (clone R4-6A2), biotinylated
rat anti-mouse IFN- mAb (clone XMG1.2), rat-anti-
mouse B220 mAb (clone RA3-6B2), and biotinylated rat
anti-mouse CD19 mAb (clone 1D3) were obtained from
PharMingen (San Diego, CA).
Cell lines
The IC21 cell line is an SV40-transformed macrophage
line derived from peritoneal macrophages of normal B6
mice and was obtained from ATCC. IC21 cells express
class I (H-2b) and class II (I-Ab) MHC molecules.
E55MuLV-infected IC21 cells express viral epitopes of
the env and gag gene products as determined by flow
cytometric staining with mAb34 and mAb48. IC21 cells
were maintained in RPMI-1640 (Media Tech, VA) wtih
10% FCS (Sigma, St. Louis, MO). 1 mM L-glutamate, 100
U penicillin, 0.1 mg streptomycin, and 5  105 M 2-mer-
captoethanol (complete medium).
Spleen cell preparations
Spleens were removed from individual mice and ho-
mogenized. Mononuclear cells were isolated by density
centrifugation. Preparations were divided into three ali-
quots: One aliquot for ex vivo ELISPOT assays (direct
ELISPOT) to determine the number of IL-2, IL-4, IL-10,
and IFN- producing cells; the second aliquot for in vitro
culture with E55MuLV-infected IC21 cells to determine
the virus-specific proliferative response; and the third
aliquot for amplified ELISPOT assays (indirect ELISPOT)
and ELISA for IL-2, IL-4, IL-10, and IFN-. Finally, to
determine the role of T and B cells in virus-specific
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proliferation and cytokine production, aliquots of the
spleen cells were depleted in vitro of either CD4 or
CD8 T cells or CD19 B cells prior to direct ELISPOT
and in vitro culture.
T cell proliferation assay
Spleen cells from individual naı¨ve or E55MuLV-in-
fected B6 mice were harvested at 2 and 4 weeks p.i. and
were cultured in complete medium in 96-well plates at
1  105 cells/well in the presence of 2.5  104 naı¨ve or
E55MuLV-infected IC21 cells. IC21 cells were treated
with mitomycin-C (50 ng/ml) for 1 h at 37°C and then
washed three to four times with PBS before use. Aliquots
of spleen cells were depleted in vitro of either CD4 or
CD8 T cells by treatment with antibody (GK1.5 or 2.43)
and complement prior to culture. The percentage of
CD4 or CD8 cells in the depleted aliquots was re-
duced to background levels (1%) as determined by flow
cytometry. Splenocytes were cultured for 72 h and pulsed
with 1.0 Ci [3H]thymidine per well during the final 12 h
of culture. Cells were harvested using a PHD cell har-
vester (Cambridge Technologies, Cambridge, MA) and
radioactivity was counted in a liquid scintillation counter
(Beckman, MD). Proliferation is expressed as net counts
per minute (Net CPM) calculated as:
Net CPM CPM of splenocytes with IC21 cells
 CPM of splenocytes alone.
ELISA for cytokines
Spleen cells from individual naı¨ve or E55MuLV-in-
fected B6 mice were cultured in complete medium in
96-well plates at 5  105 cells/well with 1  105
E55MuLV-infected IC21 cells. IC21 cells were treated
as described above. Aliquots of cells were depleted in
vitro of CD4 or CD8 T cells or CD19 B cells before
culture. T cell subsets were depleted as described
above. B cells were depleted by treatment with anti-CD19
mAb and then by binding of the labeled cells to a mag-
netic column obtained from Stem Cell Technologies
(Canada). Depletion of B cells was performed following
the recommended protocol provided by the manufac-
turer. The percentage of B cells in the depleted aliquots
was reduced to background levels (1%) as determined
by flow cytometry with anti-B220 mAb.
Initial experiments established that the optimal time
for detection of cytokine in culture supernatant was 40 h
for IL-2 and IL-4 and 60 h for IFN- and IL-10. Superna-
tants were stored at 70°C until tested by sandwich
ELISA specific for each cytokine. Cytokine ELISA was
performed following the recommended protocol provided
by PharMingen. Level of detection of IL-2 and IL-4  15
pg/ml; IFN- and IL-10  62.5 pg/ml. Results for IL-2 are
expressed as pg/ml of culture supernatant. Results for
IFN- and IL-10 are expressed as net cytokine in pg/ml
(Net pg/ml) calculated as:
Net Cytokine Cytokine with inf. IC21 cells
 Cytokine with uninf. IC21 cells.
Cytokine ELISPOT assay
Spleen cells from individual naı¨ve or E55MuLV in-
fected B6 mice were either used direclty in ex vivo
ELISPOT assays or amplified by in vitro culture prior to
ELISPOT assay. For the culture, spleen cells were incu-
bated at 1  106 cells/well in a 24-well plate either alone
or with 2  105 E55MuLV-infected IC21 cells in com-
plete medium at 37°C in 5% CO2 for 48 h (the time
established as optimal in preliminary experiments). Ali-
quots of the spleen cells were depleted in vitro of CD4
or CD8 T cells prior to ex vivo ELISPOT assays or
amplification culture described above. After culture, cells
were washed, counted, resuspended in complete me-
dium, and used in the ELISPOT assay (Klinmann and
Nutman, 1995). Briefly, Immunlon II plates (Dynatech,
Chantilly, VA) were coated overnight at 4°C with anti-
mouse capture mAb (either 2 g/ml of anti-IL-2 or 5
g/ml of anti-IFN- in PBS). Plates were washed three
times with PBS/Tween-20 (0.5%) and blocked with com-
plete media for 2 h at 37°C. Spleen cells of both ex vivo
and in vitro culture were added to individual wells at
twofold serial dilutions (4  105–1  105 cells/well) and
incubated for 20 h at 37°C. Plates were then washed
three times with PBS followed by three additional times
with PBS/Tween-20 (0.5%). Biotinylated detection mAb for
both IL-2 and IFN- was diluted to 2 g/ml in PBS/
Tween-20 (0.5%) and was added to the wells. Plates were
incubated overnight at 4°C and then washed three times
with PBS followed by three additional times with PBS/
Tween-20 (0.5%). Strepavidin-akaline phosphatase
(Sigma), diluted in PBS/Tween-20 and 5% FCS, was
added and the plates were incubated for 1 h at 37°C.
Plates were washed five times with PBS/Tween-20 (0.5%)
and then with BCIP (5-bromo-4-chloro-3-indolyl phos-
phate) (Sigma) at 1 mg/ml in AMP buffer (0.15 M 2-amino-
2-methyl-1-propanol) containing 0.6% agarose was
added to the wells. The plates were stored at room
temperature until the agarose set and were scored the
next day. Cytokine-producing cells were counted with the
aid of a dissecting microscope (SZH Zoom stereo micro-
scope, Olympus, Lake Success, NY). All scoring was
performed by a single investigator in a coded manner.
Results for IL-2 are expressed as the number of cytokine-
producing cells per 106 cells. Results for IFN- are ex-
pressed as net IFN- producing cells per 106 cells cal-
culated as:
Net IFN- cells IFN- cells with inf. IC21
 IFN- cells with uninf. IC21 cells.
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Statistical analysis
All statistics were performed using JMP software ver-
sion 3.2.6 (SAS Institute). Statistical significance (except
for T cell proliferation) was determined using Mann–
Whitney U test. Unpaired Student’s t test was used to
determine statistical significance for T cell proliferation.
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